CH616648A5 - - Google Patents

Download PDF

Info

Publication number
CH616648A5
CH616648A5 CH169075A CH169075A CH616648A5 CH 616648 A5 CH616648 A5 CH 616648A5 CH 169075 A CH169075 A CH 169075A CH 169075 A CH169075 A CH 169075A CH 616648 A5 CH616648 A5 CH 616648A5
Authority
CH
Switzerland
Prior art keywords
acid
hydrogen
hydroxy
heart
group
Prior art date
Application number
CH169075A
Other languages
German (de)
English (en)
Inventor
Enar Ingemar Carlsson
Nils Henry Alfons Persson
Gustav Benny Roger Samuelsson
Kjell Ingvar Leopold Wetterlin
Original Assignee
Haessle Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Haessle Ab filed Critical Haessle Ab
Publication of CH616648A5 publication Critical patent/CH616648A5/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C217/00—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton
    • C07C217/52—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups or amino groups bound to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/138—Aryloxyalkylamines, e.g. propranolol, tamoxifen, phenoxybenzamine
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C217/00—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton
    • C07C217/02—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton
    • C07C217/04—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated
    • C07C217/28—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having one amino group and at least two singly-bound oxygen atoms, with at least one being part of an etherified hydroxy group, bound to the carbon skeleton, e.g. ethers of polyhydroxy amines
    • C07C217/30—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having one amino group and at least two singly-bound oxygen atoms, with at least one being part of an etherified hydroxy group, bound to the carbon skeleton, e.g. ethers of polyhydroxy amines having the oxygen atom of at least one of the etherified hydroxy groups further bound to a carbon atom of a six-membered aromatic ring
    • C07C217/32—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having one amino group and at least two singly-bound oxygen atoms, with at least one being part of an etherified hydroxy group, bound to the carbon skeleton, e.g. ethers of polyhydroxy amines having the oxygen atom of at least one of the etherified hydroxy groups further bound to a carbon atom of a six-membered aromatic ring the six-membered aromatic ring or condensed ring system containing that ring being further substituted
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C217/00—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton
    • C07C217/02—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton
    • C07C217/04—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated
    • C07C217/28—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having one amino group and at least two singly-bound oxygen atoms, with at least one being part of an etherified hydroxy group, bound to the carbon skeleton, e.g. ethers of polyhydroxy amines
    • C07C217/30—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having one amino group and at least two singly-bound oxygen atoms, with at least one being part of an etherified hydroxy group, bound to the carbon skeleton, e.g. ethers of polyhydroxy amines having the oxygen atom of at least one of the etherified hydroxy groups further bound to a carbon atom of a six-membered aromatic ring
    • C07C217/32—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having one amino group and at least two singly-bound oxygen atoms, with at least one being part of an etherified hydroxy group, bound to the carbon skeleton, e.g. ethers of polyhydroxy amines having the oxygen atom of at least one of the etherified hydroxy groups further bound to a carbon atom of a six-membered aromatic ring the six-membered aromatic ring or condensed ring system containing that ring being further substituted
    • C07C217/34—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having one amino group and at least two singly-bound oxygen atoms, with at least one being part of an etherified hydroxy group, bound to the carbon skeleton, e.g. ethers of polyhydroxy amines having the oxygen atom of at least one of the etherified hydroxy groups further bound to a carbon atom of a six-membered aromatic ring the six-membered aromatic ring or condensed ring system containing that ring being further substituted by halogen atoms, by trihalomethyl, nitro or nitroso groups, or by singly-bound oxygen atoms
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
CH169075A 1974-02-14 1975-02-12 CH616648A5 (it)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE7401958A SE388849B (sv) 1974-02-14 1974-02-14 Forfarande for framstellning av nya aminer med beta-receptorstimulerande verkan

Publications (1)

Publication Number Publication Date
CH616648A5 true CH616648A5 (it) 1980-04-15

Family

ID=20320208

Family Applications (1)

Application Number Title Priority Date Filing Date
CH169075A CH616648A5 (it) 1974-02-14 1975-02-12

Country Status (23)

Country Link
US (2) US4244969A (it)
JP (1) JPS50116433A (it)
AT (1) AT334881B (it)
AU (1) AU497441B2 (it)
BE (1) BE825515A (it)
CA (1) CA1052387A (it)
CH (1) CH616648A5 (it)
CS (2) CS202035B2 (it)
DD (1) DD118614A5 (it)
DE (1) DE2502993A1 (it)
DK (1) DK135711B (it)
FI (1) FI62055B (it)
FR (1) FR2261000B1 (it)
GB (1) GB1492647A (it)
HU (1) HU169704B (it)
IE (1) IE41350B1 (it)
IT (1) IT7950875A0 (it)
LU (1) LU71846A1 (it)
NL (1) NL7501785A (it)
NO (1) NO140628C (it)
SE (1) SE388849B (it)
SU (3) SU603332A3 (it)
ZA (1) ZA75381B (it)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4210653A (en) * 1978-06-27 1980-07-01 Merck & Co., Inc. Pyridyloxypropanolamines
SE8004088L (sv) 1980-06-02 1981-12-03 Haessle Ab Nya substituerade 3-fenoxi-l-alkoxikarbonylalkylamino-propanol-2-er med beta-receptorblockerande egenskaper samt forfarande for deras framstellning, farmaceutiska beredningar innehallande desamma och metod att ...
US4396629A (en) * 1980-12-29 1983-08-02 Sterling Drug Inc. Compositions, processes and method
CA1262729A (en) * 1983-10-19 1989-11-07 Leo Alig Phenoxypropanolamines
US5166218A (en) * 1983-10-19 1992-11-24 Hoffmann-La Roche Inc. Phenoxypropanolamines and pharmaceutical compositions thereof
SE457505B (sv) * 1984-01-10 1989-01-09 Lejus Medical Ab Laminatbelagd oral farmaceutisk komposition och foerfarande foer dess framstaellning
DE3544172A1 (de) * 1985-12-13 1987-06-19 Lentia Gmbh Neue kristalline salze von aryloxy-propanolaminen, verfahren zu ihrer herstellung und ihre verwendung
DE3773188D1 (de) * 1987-03-26 1991-10-24 Helopharm Petrik Co Kg Verfahren zur herstellung von 5-hydroxydiprafenon und seiner salze mit saeuren.
EA002984B1 (ru) * 1996-04-09 2002-12-26 Эн Пи Эс Фармасьютикалз, Инк. Кальцилитические соединения, фармацевтические композиции и способ скрининга кальцилитических соединений
US6818660B2 (en) 1996-04-09 2004-11-16 Nps Pharmaceuticals, Inc. Calcilytic compounds
US5966498A (en) * 1996-08-07 1999-10-12 Lakewood Engineering And Manufacturing Company End closure assembly for oil-filled heater
TW483881B (en) 1996-12-03 2002-04-21 Nps Pharma Inc Calcilytic compounds
US7202261B2 (en) 1996-12-03 2007-04-10 Nps Pharmaceuticals, Inc. Calcilytic compounds
JP4604583B2 (ja) * 2004-07-20 2011-01-05 ダイソー株式会社 １−アミド−３−（２−ヒドロキシフェノキシ）−２−プロパノール誘導体、ならびに２−アミドメチル−１，４−ベンゾジオキサン誘導体の製造法
IL165365A0 (en) 2004-11-24 2006-01-15 Q Core Ltd Finger-type peristaltic pump
JP4934287B2 (ja) * 2005-04-05 2012-05-16 花王株式会社 美白剤
FR2916441B1 (fr) * 2007-05-22 2009-08-28 Clariant Specialty Fine Chem Procede de racemisation d'alpha-aminoacetals optiquement actifs.

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL301580A (it) * 1962-12-11
GB1069345A (en) * 1963-07-19 1967-05-17 Ici Ltd New alkanolamine derivatives
DE1922003C3 (de) * 1969-04-30 1979-10-11 Boehringer Mannheim Gmbh, 6800 Mannheim N-(3-Aryloxy-2-hydroxypropyl)-aminocarbonsäuren, deren Ester, Amide und Salze, Verfahren zur Herstellung dieser Verbindungen und deren Verwendung bei der Bekämpfung von Herzinsuffizienz
BE790165A (fr) * 1971-12-14 1973-02-15 Parke Davis & Co Nouveaux aminoalcanols et procede pour les preparer

Also Published As

Publication number Publication date
NL7501785A (nl) 1975-08-18
FI750390A (it) 1975-08-15
IE41350B1 (en) 1979-12-19
DE2502993A1 (de) 1975-09-04
CA1052387A (en) 1979-04-10
FR2261000A1 (it) 1975-09-12
CS202036B2 (en) 1980-12-31
BE825515A (fr) 1975-08-14
SU603332A3 (ru) 1978-04-15
DK135711B (da) 1977-06-13
HU169704B (it) 1977-02-28
CS202035B2 (en) 1980-12-31
DK53975A (it) 1975-10-06
SE7401958L (it) 1975-08-15
NO140628C (no) 1979-10-10
DD118614A5 (it) 1976-03-12
DK135711C (it) 1977-11-21
SE388849B (sv) 1976-10-18
US4336267A (en) 1982-06-22
LU71846A1 (it) 1975-12-09
SU609460A3 (ru) 1978-05-30
FI62055B (fi) 1982-07-30
AT334881B (de) 1977-02-10
AU497441B2 (en) 1978-12-14
US4244969A (en) 1981-01-13
IT7950875A0 (it) 1979-11-21
NO140628B (no) 1979-07-02
SU577971A3 (ru) 1977-10-25
ATA96475A (de) 1976-06-15
GB1492647A (en) 1977-11-23
IE41350L (en) 1975-08-14
JPS50116433A (it) 1975-09-11
FR2261000B1 (it) 1978-07-21
AU7811675A (en) 1976-08-12
ZA75381B (en) 1976-01-28
NO750468L (it) 1975-08-15

Similar Documents

Publication Publication Date Title
CH616648A5 (it)
AT327174B (de) Verfahren zur herstellung von neuen sulfamiden und deren saureadditionssalzen
DD211783A5 (de) Verfahren zur herstellung von 2-/2'-hydroxy-3'-(1,1-dimethylpropylamino)-propoxy/-beta-phenylpropiophenon
DE2817083A1 (de) Benzylisochinolin-derivate, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneipraeparate
EP0147707A2 (de) 1,7-Diphenyl-3-methylaza-7-cyan-8-methyl-nonan zur Verwendung bei der Bekämpfung von Krankheiten
EP0225543B1 (de) Basisch substituierte Phenylacetaldehyde, ihre Herstellung und diese enthaltende Arzneimittel
EP0045911B1 (de) Neue Aminopropanol-Derivate, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel
CH636337A5 (en) Process for preparing novel amines having beta receptor-inhibiting activity
CH618416A5 (en) Process for the preparation of novel hydroxyamines
AT345790B (de) Verfahren zur herstellung von neuen substituierten 3-phenoxy-2-hydroxy-1- aminopropanen und deren saeureaddtionssalzen
EP0013252A1 (de) Mittel zur Senkung der Herzfrequenz
EP0269985A2 (de) Neue 1-Aryloxy-3-amino-2-propanole, ihre Herstellung und Verwendung
DE1950351C3 (de) l-(2-Cyano-5-methylphenoxy)-2-hydroxy-3-aIkylaminopropane, Verfahren zu ihrer Herstellung sowie diese enthaltende Arzneimittel
CH651754A5 (de) Pharmazeutische zusammensetzung, besonders mit antiarrhythmischer und subsidiaerer wirkung bei der hypoxie des myokards, sowie ein verfahren zu ihrer herstellung.
AT375365B (de) Verfahren zur herstellung von neuen 2-pyridylalkyl-sulfinyl-benzimidazolen, von deren hydraten, stereoisomeren und salzen
CH632987A5 (en) Process for preparing novel amines
AT294072B (de) Verfahren zur Herstellung von neuen Benzofuranderivaten und ihren Salzen
AT363067B (de) Verfahren zur herstellung von neuen 3-phenoxy-2-hydroxy-1-phenoxy- oder -1-phenylthioalkylamino-propanen und von deren saeureadditionssalzen
AT329577B (de) Verfahren zur herstellung von neuen 2- (morpholino) -1-(3-trifluormethylphenyl)-propanderivaten ihren salzen und optischen isomeren
AT374472B (de) Verfahren zur herstellung von neuen 2-pyridylalkylthio-benzimidazolen sowie von deren hydraten, stereoisomeren und salzen
DE1618160C3 (de) l-(2-Äthinylphenoxy)-2-hydroxy-3alkylaminopropane, ihre physiologisch verträglichen Säureadditionssalze, Verfahren zu ihrer Herstellung, sowie diese Verbindungen enthaltende Arzneimittel
DE2207460A1 (de) Neues lungentherapeutikum
AT281046B (de) Verfahren zur herstellung von neuen benz-epinderivaten und ihren saeureadditionssalzen
AT353250B (de) Verfahren zur herstellung von neuen 3-phenoxy-2 -hydroxy-1-phenoxy- oder -1- phenylthioalkyl- amino-propanen und von deren saeureadditions- salzen
AT311350B (de) Verfahren zur Herstellung von neuen 1,2,3,6,-Tetrahydro-4-pyridylmethyl-carbonsäureestern, deren Säureadditionssalzen und quaternären Ammoniumverbindungen

Legal Events

Date Code Title Description
PL Patent ceased